By James F. Tracy
The transnational pharmaceutical cartel will be positioning itself to profit handsomely if a federally-mandated adult immunization program becomes law. The proposed US Department of Health and Human Services (HHS) policy will be implemented alongside the Obama administration’s Affordable Care Act (ACA), thereby becoming a standard component of US national healthcare policy.
“The vision for adult immunization is to protect the public health and achieve optimal prevention of infectious diseases and their consequences through vaccination of all adults” (emphasis retained, p. 6).
The subpoint strategies of each goal are summarized below, although it should be noted that the original document contains highly detailed strategies for achieving each (pp. 11-25) .
1: Strengthen the adult 
immunization infrastructure.
Objective 1.1: Monitor and report trends in adult vaccine-preventable disease levels and vaccination coverage data for all ACIP-recommended vaccines. In cases where there are associated Healthy People 2020 goals, measure progress toward established targets.
Objective 1.2: Enhance current vaccine safety monitoring systems and develop new methods to accurately and more rapidly assess vaccine safety and effectiveness in adult populations (e.g., pregnant women).
Objective 1.3: Continue to analyze claims filed as part of the National Vaccine Injury Compensation Program (VICP) to identify potential causal links between vaccines and adverse events.
Objective 1.4: Increase the use of electronic health records (EHRs) and immunization information systems (IIS) to collect and track adult immunization data.
Objective 1.5: Evaluate and advance targeted quality improvement initiatives.
Objective 1.6: Generate and disseminate evidence about the health and economic impact of adult immunization, including potential disease burden averted and cost-effectiveness with the use of current vaccines.
2: Improve access to adult vaccines.
Objective 2.1: Reduce financial barriers for individuals who receive vaccines routinely recommended for adults.
Objective 2.2: Assess and improve understanding of providers’ financial barriers to delivering vaccinations, including to stocking and administering vaccines.
Objective 2.3: Expand the adult immunization provider network.
Objective 2.4: Ensure a reliable supply of vaccines and the ability to track vaccine inventories, including during public health emergencies.
3. Increase community demand for adult immunizations.
Objective 3.1: Educate and encourage individuals to be aware of and receive recommended adult immunizations.
Objective 3.2: Educate, encourage, and motivate health care professionals to recommend and/or deliver adult vaccinations.
Objective 3.3: Educate and encourage other groups (e.g., community and faith-based groups, tribal organizations)to promote the importance of adult immunization.
4: Foster innovation in adult vaccine development and vaccination-related technologies.
Objective 4.1: Develop new vaccines and improve the effectiveness of existing vaccines for adults.
Objective 4.2: Encourage new technologies to improve the distribution, storage, and delivery of adult vaccines.
Published on February 6, 2015 amid the “measles outbreak” media frenzy, the HHS is accepting “public comment” on its Draft National Adult Immunization Plan (NAIP) until March 9, 2015. Under the NAIP, all adult American citizens will be compelled to receive current and retroactive vaccination regimens that may amount to several dozen “shots” per individual during their “catch-up” phase.
